Status:
COMPLETED
Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
Lead Sponsor:
Uppsala University
Conditions:
Infectious Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The overall aim of the project is to fill an important knowledge gap on the ecological effects of selected antibiotics. The results will be used to guide treatment decisions for common infections to a...
Detailed Description
Background: The rationale behind this project is that different antibiotics have varying effects on the intestinal microbiota, which has clinical implications. To investigate the relative collateral d...
Eligibility Criteria
Inclusion
- Signed written informed consent
- Age ≥ 18 years
Exclusion
- Chronic disease, allergy, asthma, recurrent infections
- Ongoing antibiotic treatment
- Antibiotic treatment the past 12 months
- Pregnancy or planned pregnancy within the study period
- Known allergy to phenoximethylpenicillin, amoxicillin and amoxicillin- clavulanic acid
- Planned travel outside Europe within one year from inclusion
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04084106
Start Date
September 10 2019
End Date
November 11 2022
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala University Hospital
Uppsala, Sweden